Advertisement
Screener

PERIMETER SOLUTIONS, INC. (PRM) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

PERIMETER SOLUTIONS, INC. Financing Cash Flow

PERIMETER SOLUTIONS, INC. (PRM) reported Financing Cash Flow of $547.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-31

  • PERIMETER SOLUTIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $4.45M.
  • PERIMETER SOLUTIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $542.76M.
  • PERIMETER SOLUTIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $12.61M, a 45.91% decline year-over-year.
  • PERIMETER SOLUTIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $18.98M.
  • PERIMETER SOLUTIONS, INC. net cash provided by (used in) financing activities for fiscal 2025 was -$8.97M, a 207.45% decline from fiscal 2024.
  • PERIMETER SOLUTIONS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $8.35M.
  • PERIMETER SOLUTIONS, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$64.45M.
  • PERIMETER SOLUTIONS, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$48.81M.
Period endNet Cash Provided by (Used in) Financing Activities 2 monthNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 10 monthNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30$4.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$547.21M
10-Q · filed 2026-07-31
$559.82M
derived: sum of 3 quarters · filed 2026-07-31
$578.80M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31$542.76M
10-Q · filed 2026-05-06
$555.38M
derived: sum of 2 quarters · filed 2026-05-06
$574.35M
derived: sum of 3 quarters · filed 2026-05-06
$542.19M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31$12.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$31.59M
derived: sum of 2 quarters · filed 2026-02-26
-$578.00K
derived: sum of 3 quarters · filed 2026-07-31
-$8.97M
10-K · filed 2026-02-26
2025-09-30$18.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$13.19M
derived: sum of 2 quarters · filed 2026-07-31
-$21.58M
10-Q · filed 2025-10-30
$1.73M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30-$32.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
-$40.56M
10-Q · filed 2026-07-31
-$17.25M
derived: sum of 3 quarters · filed 2026-07-31
-$17.43M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31-$8.39M
10-Q · filed 2026-05-06
$14.92M
derived: sum of 2 quarters · filed 2026-05-06
$14.74M
derived: sum of 3 quarters · filed 2026-05-06
$14.41M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$23.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$23.13M
derived: sum of 2 quarters · filed 2026-02-26
$22.80M
derived: sum of 3 quarters · filed 2026-02-26
$8.35M
10-K · filed 2026-02-26
2024-09-30-$180.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$514.00K
derived: sum of 2 quarters · filed 2025-10-30
-$14.96M
10-Q · filed 2025-10-30
-$41.92M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$334.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$14.78M
10-Q · filed 2025-08-07
-$41.74M
derived: sum of 3 quarters · filed 2026-02-26
-$51.92M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$14.45M
10-Q · filed 2025-05-08
-$41.41M
derived: sum of 2 quarters · filed 2026-02-26
-$51.59M
derived: sum of 3 quarters · filed 2026-02-26
-$78.04M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$26.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$37.14M
derived: sum of 2 quarters · filed 2026-02-26
-$63.59M
derived: sum of 3 quarters · filed 2026-02-26
-$64.45M
10-K · filed 2026-02-26
2023-09-30-$10.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$36.63M
derived: sum of 2 quarters · filed 2024-11-12
-$37.50M
10-Q · filed 2024-11-12
-$79.27M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30-$26.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
-$27.32M
10-Q · filed 2024-08-01
-$69.08M
derived: sum of 3 quarters · filed 2025-02-20
-$71.65M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31-$864.00K
10-Q · filed 2024-05-09
-$42.63M
derived: sum of 2 quarters · filed 2025-02-20
-$45.20M
derived: sum of 3 quarters · filed 2025-02-20
-$50.20M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31-$41.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
-$44.33M
derived: sum of 2 quarters · filed 2025-02-20
-$49.34M
derived: sum of 3 quarters · filed 2025-02-20
-$48.81M
10-K · filed 2025-02-20
2022-09-30-$2.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$7.57M
derived: sum of 2 quarters · filed 2023-11-09
-$7.04M
10-Q · filed 2023-11-09
2022-06-30-$5.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
-$4.48M
10-Q · filed 2023-08-03
2022-03-31$529.00K
10-Q · filed 2023-05-10
2021-12-31-$697.22M
10-K · filed 2024-02-22
2021-11-08-$64.21M
10-K · filed 2024-02-22
2021-09-30-$5.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
-$2.81M
derived: sum of 2 quarters · filed 2022-11-04
-$4.21M
10-Q · filed 2022-11-04
-$24.01M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$3.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
$1.69M
10-Q · filed 2022-08-05
-$18.11M
derived: sum of 3 quarters · filed 2023-03-01
2021-03-31-$1.40M
10-Q · filed 2022-05-10
-$21.20M
derived: sum of 2 quarters · filed 2023-03-01
2020-12-31-$19.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$45.61M
10-K · filed 2023-03-01
2020-09-30-$25.81M
10-Q · filed 2021-12-14
2019-12-31$21.03M
10-K · filed 2022-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
BALCHEM CORP (BCPC)United States$5.347B32.84
Ingevity Corp (NGVT)United States$2.468B47.72
INNOSPEC INC. (IOSP)United States$2.380B16.37
Chemours Co (CC)United States$2.136B-10.64
OLIN Corp (OLN)United States$1.852B-11.54
Huntsman CORP (HUN)United States$1.540B-6.95
FMC CORP (FMC)United States$1.201B-0.52
Ecovyst Inc. (ECVT)United States$1.110B-22.22
Solstice Advanced Materials Inc. (SOLS)United States$8.905B67.02
ASCENT INDUSTRIES CO. (ACNT)United States$0.132B-30.55